Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001193125-17-148178
Filing Date
2017-04-28
Accepted
2017-04-28 16:14:03
Documents
3
Period of Report
2016-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A d376220d10ka.htm 10-K/A 243325
2 EX-31.3 d376220dex313.htm EX-31.3 6384
3 EX-31.4 d376220dex314.htm EX-31.4 6334
  Complete submission text file 0001193125-17-148178.txt   257031
Mailing Address 87 CAMBRIDGEPARK DRIVE CAMBRIDGE MA 02140
Business Address 87 CAMBRIDGEPARK DRIVE CAMBRIDGE MA 02140 617 621 8097
Dicerna Pharmaceuticals Inc (Filer) CIK: 0001399529 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-36281 | Film No.: 17795695
SIC: 2834 Pharmaceutical Preparations